Provided by Tiger Fintech (Singapore) Pte. Ltd.

AbbVie

186.06
+5.693.15%
Post-market: 185.94-0.1210-0.07%19:59 EDT
Volume:10.48M
Turnover:1.94B
Market Cap:329.14B
PE:79.52
High:188.70
Open:187.12
Low:179.99
Close:180.37
Loading ...

AbbVie Inc. (ABBV): Among Billionaire Ken Fisher’s Healthcare Stock Picks with Massive Upside Potential

Insider Monkey
·
4 hours ago

AbbVie First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.
·
Yesterday

AbbVie Inc (ABBV) Q1 2025 Earnings Call Highlights: Strong Growth in Immunology and Neuroscience Drive Revenue Surge

GuruFocus
·
26 Apr

Q1 2025 AbbVie Inc Earnings Call

Thomson Reuters StreetEvents
·
26 Apr

Health Care Up as AbbVie Rises on Earnings -- Health Care Roundup

Dow Jones
·
26 Apr

Another drugmaker says tax reform, not tariffs, would drive U.S. manufacturing

Dow Jones
·
26 Apr

AbbVie (NYSE:ABBV) Reports US$13 Billion Sales, Submits Application For New Neurotoxin

Simply Wall St.
·
26 Apr

AbbVie Stock Rises Despite Risks as Earnings Beat Forecasts -- Barrons.com

Dow Jones
·
26 Apr

Drugmaker Abbvie Ramps Up Domestic Manufacturing Plans on Tariff Threats -- WSJ

Dow Jones
·
26 Apr

Top Midday Stories: Alphabet Q1 Earnings, Revenue Rise; Apple Reportedly Plans to Shift US iPhone Production to India

MT Newswires Live
·
25 Apr

AbbVie Raises Profit Outlook But Flags Tariff Risks In Pharma Sector

Benzinga
·
25 Apr

AbbVie Raises Full-Year Outlook as First-Quarter Results Top Street Estimates

MT Newswires
·
25 Apr

AbbVie Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
25 Apr

Report Says 25% Pharma Tariff Would Raise US Drug Prices by $51 Billion Annually, Reuters Reports

MT Newswires Live
·
25 Apr

AbbVie sees Q2 adjusted EPS $3.26-$3.30, consensus $3.05

TIPRANKS
·
25 Apr

Abbvie Shares up 3.2% After Co Lifts FY Profit Forecast

THOMSON REUTERS
·
25 Apr

AbbVie sees FY25 adjusted gross margin 84% of sales

TIPRANKS
·
25 Apr

AbbVie (ABBV) Reports Q1 Earnings: What Key Metrics Have to Say

Zacks
·
25 Apr

BUZZ-U.S. STOCKS ON THE MOVE-Phillips 66, AbbVie, SLB

Reuters
·
25 Apr

Abbvie Exec Hopes the Administration Contemplates the Harm That International Reference Pricing Could Have on US Healthcare Industry and Innovation

THOMSON REUTERS
·
25 Apr